Key Events This Week
15 Sep: Intraday low amid price pressure at Rs.104.4
16 Sep: Intraday high surge of 7.39% to Rs.114.4 with exceptional volume
17 Sep: Volume surge and positive momentum pushing price near 52-week high
18 Sep: New 52-week and all-time high at Rs.123.5, closing at Rs.120.90
15 September 2026: Intraday Low Amid Price Pressure
Morepen Laboratories Ltd opened the week under pressure, closing at Rs.106.25, down 8.37% from the previous close. The stock hit an intraday low of Rs.104.4, a 9.96% drop, reflecting significant volatility and selling pressure amid a broadly negative market environment. The Sensex also declined sharply by 1.69%, closing at 35,169.62. Despite this weakness, the stock remained above its longer-term moving averages, indicating that medium- and long-term trends were still intact.
The stock underperformed its Pharmaceuticals & Biotechnology sector by 6.12% on the day, highlighting sector-specific challenges. Technical indicators showed a divergence with bearish short-term momentum but bullish signals on weekly and monthly charts. The Mojo Score of 64.0 and Hold rating suggest a moderate outlook despite the intraday weakness.
16 September 2026: Strong Intraday Rally and Exceptional Volume
The stock rebounded sharply on 16 September, surging 7.86% to close at Rs.114.60, significantly outperforming the Sensex’s modest 0.30% gain. Morepen Laboratories touched an intraday high of Rs.114.4, marking a 7.39% increase from the previous close. This rally was accompanied by exceptional trading volume of over 8.48 million shares, reflecting heightened investor interest.
Despite the strong close, the stock experienced notable intraday volatility, with a low of Rs.97.25 early in the session. The price action suggested a complex interplay of profit-taking and accumulation. Technical indicators remained bullish on medium- and long-term timeframes, with the stock trading above key moving averages except the 5-day average, indicating some short-term consolidation.
Investor participation increased, with delivery volumes rising, signalling accumulation by longer-term holders despite short-term price weakness. The stock outperformed its sector by 7.22%, underscoring its relative strength amid a cautious market.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
17 September 2026: Volume Surge and Positive Momentum
On 17 September, Morepen Laboratories Ltd emerged as one of the most actively traded stocks, with a remarkable volume of 18.9 million shares and a traded value of approximately ₹224.25 crores. The stock opened at Rs.115.00 and climbed to an intraday high of Rs.120.90, closing near Rs.119.35 by midday, reflecting a 5.28% gain from the previous close.
The price action was characterised by a narrow trading range around the weighted average price, indicating strong accumulation by investors. The stock traded above all key moving averages, signalling sustained upward momentum and proximity to its 52-week high of Rs.122.55, just 2.23% away.
Delivery volumes increased by 115.7% compared to the five-day average, confirming genuine buying interest. The stock outperformed its sector by 3.34% and the Sensex by a substantial margin, reinforcing its leadership within the Pharmaceuticals & Biotechnology space.
18 September 2026: New 52-Week and All-Time Highs Amid Mixed Price Action
Morepen Laboratories Ltd reached a new 52-week and all-time high of Rs.123.50 on 18 September, marking a significant milestone. Despite touching this peak, the stock closed slightly lower at Rs.120.90, down 0.31% on the day, underperforming its sector by 1.85%. The Sensex posted a modest gain of 0.52%, closing at 35,625.23.
The stock’s year-to-date return stands at an impressive 179.16%, vastly outperforming the Sensex’s decline of 12.77%. Technical indicators remain predominantly bullish, with the stock trading above all major moving averages and supported by positive weekly and monthly momentum signals. However, the Relative Strength Index (RSI) suggests short-term overbought conditions, indicating potential for consolidation or minor pullbacks.
Trading volume remained elevated, with over 6 million shares changing hands, and delivery volumes rising by 19.25% compared to recent averages. This volume surge amid a narrow trading range reflects a tussle between buyers and sellers near the peak price levels, signalling cautious positioning by market participants.
Considering Morepen Laboratories Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - + beyond scope
- - Top-rated alternatives ready
Weekly Price Performance: Morepen Laboratories Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-15 | Rs.106.25 | -8.37% | 35,169.62 | -1.69% |
| 2026-09-16 | Rs.114.60 | +7.86% | 35,276.25 | +0.30% |
| 2026-09-17 | Rs.120.65 | +5.28% | 35,439.31 | +0.46% |
| 2026-09-18 | Rs.120.90 | +0.21% | 35,625.23 | +0.52% |
Key Takeaways
Morepen Laboratories Ltd demonstrated resilience and strong recovery after an initial sharp decline on 15 September. The stock’s ability to rebound with a 7.86% gain the following day amid exceptional volume highlights robust investor interest and underlying strength.
The surge in delivery volumes across the week indicates accumulation by longer-term investors, supporting the stock’s upward momentum. Trading above all major moving averages and nearing its 52-week high reflects a sustained bullish trend despite short-term volatility.
However, the slight price decline on 18 September amid high volume and proximity to all-time highs suggests cautious profit-taking and potential consolidation ahead. The bearish RSI signals on weekly and monthly charts warrant attention for possible short-term corrections.
The Mojo Score of 64.0 and Hold rating reflect a balanced outlook, acknowledging the stock’s strong performance and technical strength while recognising the risks inherent in its small-cap status and recent volatility.
Conclusion
Morepen Laboratories Ltd’s week was marked by significant price swings, exceptional trading volumes, and a notable milestone of reaching new 52-week and all-time highs. The stock outperformed the Sensex by a wide margin, closing the week with a 4.27% gain versus the benchmark’s 0.41% decline.
While the technical and fundamental indicators remain largely positive, the mixed signals from momentum and strength metrics suggest investors should monitor price action closely for signs of consolidation or further upside. The increased delivery volumes and accumulation patterns provide a constructive backdrop, but the stock’s small-cap nature and recent volatility advise a measured approach.
Overall, Morepen Laboratories Ltd stands out as a high-momentum small-cap stock within the Pharmaceuticals & Biotechnology sector, offering a compelling risk-reward profile amid a complex market environment.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
